Navigation Links
Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
Date:4/2/2008

Furthermore, Bavarian Nordic has appointed a new CFO. Ole Larsen (42) will join the company as Executive Vice President Finance on 1 October 2008 at the latest. He currently holds the position as Finance Director and member of the management in Nordisk Film. Previously amongst others he worked as Finance Director at Berlingske Tidende.

Reiner Laus, MD., President & CEO of Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics Inc., will also join the Executive Management. Reiner Laus was previously Vice President of Research and Development at Dendreon Corporation in Seattle, Washington where he was responsible for discovery, pre-clinical and development functions.
Executive Management hereafter consists of the following:

Anders Hedegaard, President & CEO

Nicolai Buhl Andersen, EVP Commercial Affairs

Paul Chaplin, EVP Research & Development

Reiner Laus, EVP, and CEO of BN ImmunoTherapeutics Inc.

Morten Max Rasmussen, EVP Transactions, Legal & IPR

Anders Gram, EVP Technical Operations

Ole Larsen, EVP Finance

Annual Report 2007 The full 2007 Annual Report was published on March 31, 2008 and is available for download on the company's website: http://www.bavarian-nordic.com

About Bavarian Nordic:

Bavarian Nordic, headquartered in Denmark, is a leading international biopharmaceutical company developing and producing innovative vaccines to prevent and treat infectious diseases and cancer.

In the U.S., Bavarian Nordic operates subsidiary companies, BN ImmunoTherapeutics, in Mountain View, California developing vaccines against cancers, and Bavarian Nordic Inc. in Washington, D.C. focused on business development, marketing, and government relations for the Bavarian Nordic Group.

For more information on Bavarian Nordic visit: http://www.bavarian-nordic.com


'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
2. Vista Partners Updates Coverage; Maintains $3.20 Target Price
3. ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
4. NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update
5. SGX Pharmaceuticals Provides Update on SGX523 Clinical Trials
6. ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results
7. ImaRx to Report Corporate Updates and 4Q07 Financial Results
8. LUMEDX Updates Real-Time Patient and Resource Scheduler for Healthcare Systems
9. InfuSystem Holdings Provides Business Update and Comments on Fourth Quarter 2007 Financial Results
10. Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008
11. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Cynvenio, a cancer diagnostics company focused ... analysis of tumor cells in the bloodstream, today announced ... decision support application powered by CollabRx, Inc. , ... test, Therapy Finder will provide breast cancer patients and ...
(Date:1/15/2014)... More than 5 million Americans are ... 3 seniors will die with Alzheimer’s or another dementia, ... have shocked many Americans into looking for ways to ... tragic age-related cognitive disorders. Jonathan Weisman, president of Biohack ...
(Date:1/15/2014)... Freeslate, Inc ., the leading ... Lupin Limited, one of India’s top five pharmaceutical companies, ... System for high throughput solid form screening. ... a wide range of quality, affordable generic and branded ...
(Date:1/14/2014)... January 14, 2014 Histogen, Inc., a ... of cells grown under simulated embryonic conditions, today announced ... with Suneva Medical, Inc. for physician-dispensed aesthetic products containing ... , This agreement is an amendment to the existing ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group with ... presented the ,JCA-Mauvernay Award, to Doctor Hirofumi Arakawa from ... his basic research on the ,identification and characterization of ... the University of Tokyo, for his applied research on ...
... the Heart Failure Society of America,s 15th Annual Scientific ... announced that B-type natriuretic peptide (BNP) may have utility ... of decompensation in advance of acute presentations.   ... sponsored by Alere Inc., is the first of its ...
... 4, 2011 Kylin Therapeutics, Inc., a leading ... received a notice of allowance from United States ... U.S. patent application. This newly allowed patent broadly ... expanded areas on Kylin,s proprietary nanoparticle technology platform, ...
Cached Biology Technology:The Japanese Cancer Association and Debiopharm Group™ Present Doctors Arakawa and Kurokawa With the 2011 'JCA-Mauvernay Award' for Their Innovative and Outstanding Research in the Field of Cancer 2The Japanese Cancer Association and Debiopharm Group™ Present Doctors Arakawa and Kurokawa With the 2011 'JCA-Mauvernay Award' for Their Innovative and Outstanding Research in the Field of Cancer 3HABIT Study Highlights Home BNP Testing May Allow for Earlier Interventions and Better Management of Heart Failure Patient 2HABIT Study Highlights Home BNP Testing May Allow for Earlier Interventions and Better Management of Heart Failure Patient 3Kylin Therapeutics Receives Notice of Allowance for Second U.S. Patent Covering Delivery of Therapeutic RNA and pRNAi Technology 2
(Date:7/9/2014)... bladders of healthy women differ from bacteria in ... to researchers from Loyola University Chicago Stritch School ... 9, 2014, in the American Society for Microbiology,s ... communities may play a role in female urinary ... common, yet poorly understood, condition with symptoms similar ...
(Date:7/9/2014)... Regulated deer hunts in Indiana state parks have helped ... damage caused by overabundant populations of white-tailed deer, a ... Michael Jenkins, associate professor of forest ecology, found that ... organizing hunts in state parks has successfully spurred the ... scarce by browsing deer. , Jenkins said that ...
(Date:7/9/2014)... Calif. Sexual selection refers to species, selection for ... special type of natural selection enhances opportunities to mate, ... , Biologists at the University of California, Riverside have ... formation of a placenta are linked. Describing the ... in the family Poeciliidae, the researchers found that species ...
Breaking Biology News(10 mins):Hunting gives deer-damaged forests in state parks a shot at recovery 2Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4
... Texas Medical School at Houston could help experts better decide ... their second pregnancies for a common bacterial infection if they ... Streptococcus, or GBS, is a type of bacterial infection that ... deadly to an infant passing through the mother,s birth canal. ...
... have found a way to pull pure oxygen from ... and a room-temperature glass of water. ,Because oxygen ... using solar electricity to split water into those elements--a ... One of the chief obstacles to that green-energy scenario ...
... WASHINGTON, DC U.S. Department of Energy (DOE) Under ... Agriculture Under Secretary for Research, Education and Economics Gale ... more than $10 million to accelerate fundamental research in ... biofuels offer one of the best near- to mid-term ...
Cached Biology News:Recurrence of group B strep high in subsequent pregnancies, say UT Houston obstetricians 2Water refineries? 2Water refineries? 3DOE and USDA announce more than $10 million in bioenergy plant feedstock research 2
... is an easy-to-use siRNA transfection reagent that ... genes in a variety of cell lines. ... an optimized, straightforward protocol. High levels of ... following transfection of 20 to 100 nM ...
... features of Tracker, plus software that rewards the ... defined period of time in a user defined ... instruments all built around a video camera, frame ... track two fields at once and up to ...
... of movement counts, similar to an infrared beam ... 6 subjects at once, in two frames of ... whole experimental group at once, and allow social ... for a variety of other spatial behavior situations, ...
... An accessory to the Spatial Behavior System. ... either entirely or automatically selected parts, and scoring ... replay or slow replay.The Spatial Behavior line is ... video camera, frame grabber, and feature extraction software ...
Biology Products: